Clinical Trials Logo

Clinical Trial Summary

The study evaluates the released myocardial substances in blood of HOCM patients after TASH procedure (small "controlled" myocardial infarction). This helps to identify new pathomechanisms and biomarker and thus provides a better understanding of development and progress of cardiac insufficiency.


Clinical Trial Description

All patients who receive a TASH procedure in the Medical Clinic I routinely receive routinely implementation of arterial pressure catheter for invasive blood pressure monitoring (usually Arteria radialis) as well as a central venous catheter. Directly after the procedure, the blood is taken through the central venous catheter. The operation is then terminated as planned.

The postoperative treatment is performed according to the Standard Operating Procedures (SOPs) of the Medical clinic I -regular blood sampling is performed to monitor the patient's cardiac, renal and hepatic lab values. The patient is released on the 3-5th post-operative day.

As part of a routine outpatient visit to the Medical Clinic I 1 week and 1 month after the TASH procedure, an anamnestic record as well as a blood analysis is made. One month after the TASH procedure, an echocardiographic follow-up of the HOCM is routinely performed.

Adverse events or serious adverse events are documented, assessed and reported in accordance with GCP (good clinical practice). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03648736
Study type Observational [Patient Registry]
Source RWTH Aachen University
Contact Robert Stöhr, Dr.
Phone +49 241 80 36351
Email rstoehr@ukaachen.de
Status Recruiting
Phase
Start date October 10, 2018
Completion date May 2021

See also
  Status Clinical Trial Phase
Completed NCT03306017 - Effects of Left Ventricular Assist Device Implantation on the Phenotype of Blood Platelets and Leucocytes N/A
Recruiting NCT02862197 - Invasive Monitoring of Pulmonary Artery Pressure (PAP) Among Dialysis Treated Patients N/A
Recruiting NCT03882580 - Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care
Recruiting NCT03673631 - Oxygenation Methods and Non-invasive Ventilation in Patients With Acute Respiratory Failure and a do Not Intubate Order
Recruiting NCT05255952 - Epicardial Stimulation of the Cardiac Autonomic Nervous System N/A
Not yet recruiting NCT03428308 - Detection and Treatment of Somatic Disease in Patients With Severe Mental Disease N/A
Completed NCT03083301 - Cardiac Resynchronization Therapy: Relevance of the Surgical Approach in the Implantation of the Left Ventricular Probe